scholarly journals Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Sarah Rank Rønnow ◽  
Rand Qais Dabbagh ◽  
Federica Genovese ◽  
Carmel B. Nanthakumar ◽  
Vikki J. Barrett ◽  
...  
2001 ◽  
Vol 16 (3) ◽  
pp. 500-505 ◽  
Author(s):  
Alessia Fornoni ◽  
Flavia Cornacchia ◽  
Guy A. Howard ◽  
Bernard A. Roos ◽  
Gary E. Striker ◽  
...  

Author(s):  
Jannie Sand ◽  
Natasja Gudmann ◽  
Sarah Rønnow ◽  
Sarah Brockbank ◽  
Simon Cruwys ◽  
...  

2012 ◽  
Vol 26 (9) ◽  
pp. 1385-1392 ◽  
Author(s):  
Lei Zhang ◽  
Xuan Zhang ◽  
Kui-Feng Li ◽  
Dong-Xiao Li ◽  
Yu-Mei Xiao ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Liang Tan ◽  
Yifang Xie ◽  
Ye Yuan ◽  
Kai Hu

The role of lncRNA growth arrest specific 5 (GAS5) in degenerative nucleus pulposus cell (NPC) apoptosis has been reported, but the mechanism of GAS5 in extracellular matrix (ECM) synthesis in intervertebral disc degeneration (IDD) remains unknown. We aimed to investigate the mechanism of GAS5 in ECM synthesis in degenerative NPCs. GAS5 expression was measured in degenerative NPCs (CP-H170) and normal NPCs (CP-H097). siRNA-mediated GAS5 knockdown was transfected to NPCs to detect cell viability and the expression of ECM-related genes (Collagen II, aggrecan, Collagen I, and MMP-3). Subcellular localization of GAS5 was analyzed. The downstream gene and pathway of GAS5 in degenerative NPCs were explored. As our results indicated, lncRNA GAS5 was upregulated in degenerative NPCs. Silencing GAS5 improved the viability of degenerative NPCs and increased ECM synthesis. GAS5 was mainly located in the cytoplasm of NPCs. LncRNA GAS5 sponged miR-26a-5p to regulate PTEN. Overexpression of miR-26a-5p promoted ECM synthesis in degenerative NPCs. Akt inhibitor LY294002 reversed the promotion of silencing GAS5 on ECM synthesis of degenerative NPCs. In conclusion, lncRNA GAS5 sponged miR-26a-5p to upregulate PTEN and inhibit the PI3K/Akt pathway, thus inhibiting ECM synthesis of degenerative NPCs.


2016 ◽  
Vol 7 (2) ◽  
pp. 299-304 ◽  
Author(s):  
R.A. Vongsa ◽  
R.A. Minerath ◽  
M.A. Busch ◽  
J. Tan ◽  
D.W. Koenig

An assay was developed that tested the ability of Lactobacillus acidophilus to outcompete a challenge of Escherichia coli in a mixed culture containing different test nutrients. Using this assay, addition of fructo-oligosaccharide to the media allowed L. acidophilus to outcompete a challenge of E. coli, whereas in a mixed culture without the prebiotic the trend was reversed. Growth curves generated for E. coli in a single culture showed that fructo-oligosaccharide did not affect growth, indicating that the carbohydrate was not toxic to E. coli. This indicates that fructo-oligosaccharides may increase the ability of beneficial microbes to outcompete a pathogenic challenge. These results were confirmed using a skin simulant model that incorporates growth of the organisms at an air-surface interface to mimic the vulvar environment. It is possible to use a co-culture assay as an in vitro screening tool to define nutrients that confer a competitive advantage to beneficial flora specific to the female urogenital tract.


1993 ◽  
Vol 150 (2 Part 2) ◽  
pp. 637-641 ◽  
Author(s):  
Laurence Baskin ◽  
Pamela S. Howard ◽  
Edward Macarak

Sign in / Sign up

Export Citation Format

Share Document